Isoniazid treatment for latent tuberculosis infection is tolerable for rheumatoid arthritis patients receiving tumor necrosis factor inhibitor therapy

BACKGROUND/AIMS: To evaluate the impact of isoniazid (INH) treatment for latent tuberculosis infection (LTBI) on the development of liver function test (LFT) abnormality and the persistence of tumor necrosis factor (TNF) inhibitors in rheumatoid arthritis (RA) patients. METHODS: We retrospectively e...

Descripción completa

Detalles Bibliográficos
Autores principales: Sung, Yoon-Kyoung, Cho, Soo-Kyung, Kim, Dam, Won, Soyoung, Choi, Chan-Bum, Kim, Tae-Hwan, Jun, Jae-Bum, Yoo, Dae-Hyun, Bae, Sang-Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129622/
https://www.ncbi.nlm.nih.gov/pubmed/28288508
http://dx.doi.org/10.3904/kjim.2016.214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129622/
https://www.ncbi.nlm.nih.gov/pubmed/28288508
http://dx.doi.org/10.3904/kjim.2016.214

Ejemplares similares